PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.\', \'Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.\', \'Department of Human Genetics, McGill University, Montréal, Québec, Canada.\', \'Kyoto-McGill International Collaborative Program in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.\', \'Japan Society for the Promotion of Science, Tokyo, Japan.\', \'Canada Excellence Research Chair in Genomic Medicine, McGill University, Montréal, Québec, Canada.\', \'Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.\', \'Medical Genetics, University of Siena, Siena, Italy.\', \'Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.\', \'Department of Twin Research, King\'s College London, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pmed.1003605
?:doi
?:hasPublicationType
?:journal
  • PLoS medicine
is ?:pmid of
?:pmid
?:pmid
  • 34061844
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.914
?:rankingScore_hIndex
  • 184
is ?:relation_isRelatedTo_publication of
?:title
  • Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all